+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Orthofix International N.V. (OFIX) - Product Pipeline Analysis, 2018 Update

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Bioventus LLC
  • DePuy Synthes Inc
  • DJO Global Inc
  • Globus Medical Inc
  • Medtronic Plc
  • NuVasive Inc
  • MORE
Orthofix International NV (Orthofix) is a medical device company that designs, develops, manufactures and distributes medical devices related to spine and orthopedic. Its solutions include spinal implants; human cellular and tissue based products; non-invasive regenerative stimulation products; external and internal fixation devices; bone cement; and devices for removal of bone cement used to fix artificial implants. Orthofix markets its products through a network of distributors, sales representatives and its subsidiaries. It has manufacturing facilities in the US and Italy; and administrative and training facilities in the US, Brazil, the UK, France, Germany, Puerto Rico and Italy. Orthofix is headquartered in the Lewisville, Texas, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Orthofix International N.V.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Bioventus LLC
  • DePuy Synthes Inc
  • DJO Global Inc
  • Globus Medical Inc
  • Medtronic Plc
  • NuVasive Inc
  • MORE
  • Orthofix International N.V. Company Overview
  • Orthofix International N.V. Company Snapshot
  • Orthofix International N.V. Pipeline Products and Ongoing Clinical Trials Overview
  • Orthofix International N.V. - Pipeline Analysis Overview
  • Business Description
  • Orthofix International N.V. - Key Facts
  • Orthofix International N.V. - Major Products and Services
  • Orthofix International N.V. Pipeline Products by Development Stage
  • Orthofix International N.V. Ongoing Clinical Trials by Trial Status
  • Orthofix International N.V. Pipeline Products Overview
  • Cervical-Stim Osteogenesis Stimulator - Odontoid Fractures
  • Cervical-Stim Osteogenesis Stimulator - Odontoid Fractures Product Overview
  • Cervical-Stim Osteogenesis Stimulator - Odontoid Fractures Clinical Trial
  • Corpectomy Device
  • Corpectomy Device Product Overview
  • FORZA XP Expandable Spacer System
  • Product Status
  • Physio-Stim Osteogenesis Stimulator - Osteoarthritis
  • Physio-Stim Osteogenesis Stimulator - Osteoarthritis Product Overview
  • Physio-Stim Osteogenesis Stimulator - Osteoarthritis Clinical Trial
  • RCStim Device
  • RCStim Device Product Overview
  • RCStim Device Clinical Trial
  • Orthofix International N.V. - Key Competitors
  • Orthofix International N.V. - Key Employees
  • Orthofix International N.V. - Key Employee Biographies
  • Orthofix International N.V. - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Recent Developments
  • Orthofix International N.V., Recent Developments
  • Apr 30, 2018: Orthofix Announces First Quarter 2018 Financial Results
  • Mar 22, 2018: Orthofix Receives FDA 510(k) Clearance of G-Beam Fusion Beaming System
  • Mar 13, 2018: Orthofix Announces Appointment of John Sicard to Board of Directors
  • Mar 07, 2018: Orthofix Secures FDA and CE Mark Approvals for New PhysioStim Bone Growth Stimulators
  • Mar 05, 2018: Publication of Data Further Confirms Effectiveness of the Orthofix Cervical-Stim Device in Improving Fusion Rates
  • Feb 26, 2018: Orthofix International Reports Fourth Quarter And Fiscal 2017 Financial Results
  • Feb 13, 2018: Orthofix Announces Initiation of Enrollment in Rotator Cuff Repair Study
  • Feb 06, 2018: Orthofix Announces 510(k) Clearance and US Limited Market Launch of FORZA XP Expandable Spacer System
  • Jan 09, 2018: Orthofix Announces Preliminary 2017 Fourth Quarter and Full Year Net Sales Results
  • Oct 30, 2017: Orthofix International Reports Third Quarter 2017 Financial Results
  • Appendix
  • Methodology
  • About
  • Contact
  • Disclaimer
List of Tables
  • Orthofix International N.V. Pipeline Products and Ongoing Clinical Trials Overview
  • Orthofix International N.V. Pipeline Products by Equipment Type
  • Orthofix International N.V. Pipeline Products by Indication
  • Orthofix International N.V. Ongoing Clinical Trials by Trial Status
  • Orthofix International N.V., Key Facts
  • Orthofix International N.V., Major Products and Services
  • Orthofix International N.V. Number of Pipeline Products by Development Stage
  • Orthofix International N.V. Pipeline Products Summary by Development Stage
  • Orthofix International N.V. Ongoing Clinical Trials by Trial Status
  • Orthofix International N.V. Ongoing Clinical Trials Summary
  • Cervical-Stim Osteogenesis Stimulator - Odontoid Fractures - Product Status
  • Cervical-Stim Osteogenesis Stimulator - Odontoid Fractures - Product Description
  • Cervical-Stim Osteogenesis Stimulator - Odontoid Fractures - A Multi-center, Open-label, Prospective Study of CervicalStim Device as Adjunctive Care Following Cervical Fusion
  • Cervical-Stim Osteogenesis Stimulator - Odontoid Fractures - Safety and Efficacy of Pulsed Electromagnetic Fields (Cervical-Stim) as an Adjunct to Enhance Union in Conservatively Treated Type II Fractures of the Odontoid Process
  • Corpectomy Device - Product Status
  • Corpectomy Device - Product Description
  • Product Status
  • FORZA XP Expandable Spacer System - Product Description
  • Physio-Stim Osteogenesis Stimulator - Osteoarthritis - Product Status
  • Physio-Stim Osteogenesis Stimulator - Osteoarthritis - Product Description
  • Physio-Stim Osteogenesis Stimulator - Osteoarthritis - A Prospective, Randomized, Double-blind, Placebo Controlled Study to Evaluate Efficacy and Safety of an Active Pulsed Electromagnetic Field for the Treatment of Osteoarthritis of the Knee
  • RCStim Device - Product Status
  • RCStim Device - Product Description
  • RCStim Device - Prospective, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of Pulsed Electromagnetic Field (PEMF) Therapy as an Adjunctive Treatment to Surgical Repair of Full Thickness Rotator Cuff Tears
  • Orthofix International N.V., Key Employees
  • Orthofix International N.V., Key Employee Biographies
  • Orthofix International N.V., Other Locations
  • Orthofix International N.V., Subsidiaries
  • Glossary
List of Figures
  • Orthofix International N.V. Pipeline Products by Equipment Type
  • Orthofix International N.V. Pipeline Products by Development Stage
  • Orthofix International N.V. Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Zimmer Biomet Holdings Inc
  • Stryker Corp
  • Smith & Nephew Plc
  • NuVasive Inc
  • Medtronic Plc
  • Globus Medical Inc
  • DJO Global Inc
  • DePuy Synthes Inc
  • Bioventus LLC
Note: Product cover images may vary from those shown
Adroll
adroll